A hypothetical biological pathway that may link SARS CoV 2 vaccinations to giant cell pathologies, via CD4 derangement due to receptor binding of HIV GP 120 homologous regions, Part 2
A hypothetical biological pathway that may link SARS CoV 2 vaccinations to giant cell pathologies, via CD4 derangement due to receptor binding of HIV GP 120 homologous regions, Part 1
PEG coating ALC-0159, amino lipid ALC-0315, and LNP formulated luciferase modRNA biodistribution information explanation, utilizing a Pfizer PDF and an EMA safety assessment
Amino acid sequence translation from the nucleotide code of the Pfizer transfection, and an assessment on the presence or lack thereof of HIV insert homology for vaccination end products
Nuclear localization sequence potentially found in Wuhan Hu 1 version of SARS CoV 2 Glycoprotein, and possible corroboration of HIV glycoprotein homology
